TP53 and cyclic hematopoiesis: Similar to CH, individuals with CCUS bearing only isolated DNMT3A mutations have a lower risk of progression to MN whereas individuals harboring TET2, ASXL1, TP53, and spliceosome mutations have higher risks of MN (50).